Google
 
Google

Please help cancer research by sponsoring us online

Please help cancer research by sponsoring us online
We are a team of Researchers at the University of Sheffield and we are taking part in the Race for Life Event in Chesterfield on 12th July 2009. Our work aims to develop treatments that target new blood vessel growth in tumours. We would really appreciate your support. Events like Race for Life are vital in funding Cancer Research UK's life-saving work into preventing, diagnosing and treating cancer. By sponsoring us now you can help more people survive cancer.

World Stem Cell Summit 2009

Thursday, November 27, 2008

Nature Clinical Practice Rheumatology - Table of Contents alert Volume 4 Issue 12

NATURE CLINICAL PRACTICE RHEUMATOLOGY

December 2008 Volume 4 Number 12

Visit Nature Clinical Practice Rheumatology online to browse the journal.

Now available at http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0pMu0Ea

"Officially endorsed by the Asia Pacific League of Associations for
Rheumatology"

====================================================================

Special Focus on Glycobiology of the Immune System brought to you by
Immunology & Cell Biology

Bringing you the latest on the glycobiology of the immune system, this
special feature and accompanying web focus explore the current
understanding of how glycans play a role in activating the adaptive
and innate immune responses.

To view this special offer FREE of charge visit
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0B7tE0Ea

====================================================================

----------------------
EDITORIAL
----------------------
A growing crisis in confidence
Peter E Lipsky
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYK0ES

----------------------
RESEARCH HIGHLIGHTS
----------------------
Adalimumab suppresses markers of structural damage in ankylosing
spondylitis
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYL0ET

IgG4+ multi-organ lymphoproliferative syndrome: a new clinical entity?
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYM0EU

Oral vaccine protects against disease in a mouse model of RA
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYN0EV

Novel anti-CD20 monoclonal antibody shows promise as therapy for RA
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYO0EW

Ten-second RAPID3 tool categorizes RA disease severity similarly to
standard indices
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYP0EX

Pegloticase reduces serum urate levels in patients with
treatment-refractory gout
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYQ0EY

Belimumab is well tolerated and depletes B cells effectively in patients
with SLE
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYR0EZ

In briefs
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYS0Ea

----------------------
GUIDELINES SUMMARY
----------------------
Screening for osteoporosis in men: comment on the American College of
Physicians clinical guidelines
Marc C Hochberg and Robert A Adler
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYT0Eb

----------------------
PRACTICE POINTS
----------------------
Is long-term etanercept therapy safe and effective in patients with
juvenile RA?
Raphael Hirsch
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYU0Ec

Do wedged insoles improve outcomes in patients with knee osteoarthritis?
Jeffrey N Katz
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYV0Ed

----------------------
CLINICAL ADVANCES
----------------------
Are patients with RA at increased risk of malignancy?
Kimme L Hyrich
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYW0Ee

Denosumab-a novel strategy to prevent structural joint damage in
patients with RA?
Georg Schett and Jean-Pierre David
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYX0Ef

First pregabalin and now duloxetine for fibromyalgia syndrome: closer
to a brave new world?
Chad S Boomershine
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYY0Eg

----------------------
VIEWPOINT
----------------------
The importance of recognizing scleroderma-type disorders in clinical
practice
Laura K Hummers
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYZ0Eh

----------------------
REVIEWS
----------------------
Issues in the design of new clinical trials for rheumatoid arthritis
therapeutics
William D Schwieterman
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYa0Eo

Mycobacterial disease in patients with rheumatic disease
Jakko van Ingen, Martin J Boeree, PN Richard Dekhuijzen and Dick van
Soolingen
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYb0Ep

Activated B cells in autoimmune diseases: the case for a regulatory
role
Stephen M Anderton and Simon Fillatreau
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYc0Eq

Common mistakes in the clinical use of bone mineral density testing
E Michael Lewiecki and Nancy E Lane
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYd0Er

----------------------
CASE STUDY
----------------------
Painful knee locking caused by gouty tophi successfully treated with
allopurinol
Soumya Chatterjee and Hakan Ilaslan
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0CCYe0Es

=====================================================================

You have been sent this Table of Contents Alert because you have opted
in to receive it. You can change or discontinue your e-mail alerts at
any time, by modifying your preferences on your nature.com account at:
http://ealerts.nature.com/cgi-bin24/DM/y/eo4p0Xztnp0HjN0Zzu0Ex
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department:
registration@nature.com

For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com

For other enquiries, please contact our customer feedback department:
feedback@nature.com

Nature Publishing Group | 75 Varick Street, 9th Floor | New York |
NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston

=====================================================================

Google

Any Comments ?.......

E-mail: manojhind2001us@gmail.com
Google
 

World Time